This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Switzer, W. M.
Right arrow Articles by Heneine, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Switzer, W. M.
Right arrow Articles by Heneine, W.

 Previous Article  |  Next Article 

Journal of Virology, August 2006, p. 7427-7438, Vol. 80, No. 15
0022-538X/06/$08.00+0     doi:10.1128/JVI.00690-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Ancient Origin and Molecular Features of the Novel Human T-Lymphotropic Virus Type 3 Revealed by Complete Genome Analysis

William M. Switzer,1* Shoukat H. Qari,1 Nathan D. Wolfe,2,3,4 Donald S. Burke,2,3 Thomas M. Folks,1 and Walid Heneine1

Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 Departments of Epidemiology,2 International Health,3 Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 212054

Received 5 April 2006/ Accepted 8 May 2006

Human T-lymphotropic virus type 3 (HTLV-3) is a new virus recently identified in two primate hunters in Central Africa. Limited sequence analysis shows that HTLV-3 is distinct from HTLV-1 and HTLV-2 but is genetically similar to simian T-lymphotropic virus type 3 (STLV-3). We report here the first complete HTLV-3 sequence obtained by PCR-based genome walking using uncultured peripheral blood lymphocytes from an HTLV-3-infected person. The HTLV-3(2026ND) genome is 8,917 bp long and is genetically equidistant from HTLV-1 and HTLV-2, sharing about 62% identity. Phylogenetic analysis of all gene regions confirms this relationship and shows that HTLV-3 falls within the diversity of STLV-3, suggesting a primate origin. However, HTLV-3(2026ND) is unique, sharing only 87% to 92% sequence identity with STLV-3. SimPlot and phylogenetic analysis did not reveal any evidence of genetic recombination with either HTLV-1, HTLV-2, or STLV-3. Molecular dating estimates that the ancestor of HTLV-3 is as old as HTLV-1 and HTLV-2, with an inferred divergence time of 36,087 to 54,067 years ago. HTLV-3 has a prototypic genomic structure, with all enzymatic, regulatory, and structural proteins preserved. Like STLV-3, HTLV-3 is missing a third 21-bp transcription element found in the long terminal repeats of HTLV-1 and HTLV-2 but instead contains a unique activator protein-1 transcription factor upstream of the 21-bp repeat elements. A PDZ motif, like that in HTLV-1, which is important for cellular signal transduction and transformation, is present in the C terminus of the HTLV-3 Tax protein. A basic leucine zipper region located in the antisense strand of HTLV-1, believed to play a role in viral replication and oncogenesis, was also found in the complementary strand of HTLV-3. The ancient origin of HTLV-3, the broad distribution of STLV-3 in Africa, and the propensity of STLVs to cross species into humans all suggest that HTLV-3 may be prevalent and support the need for expanded surveillance for this virus.


* Corresponding author. Mailing address: Laboratory Branch, Division of HIV/AIDS Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Rd., MS G-45, Atlanta, GA 30333. Phone: (404) 639-0219. Fax: (404) 639-1174. E-mail: bis3{at}cdc.gov.


Journal of Virology, August 2006, p. 7427-7438, Vol. 80, No. 15
0022-538X/06/$08.00+0     doi:10.1128/JVI.00690-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Moens, B., Lopez, G., Adaui, V., Gonzalez, E., Kerremans, L., Clark, D., Verdonck, K., Gotuzzo, E., Vanham, G., Cassar, O., Gessain, A., Vandamme, A.-M., Van Dooren, S. (2009). Development and Validation of a Multiplex Real-Time PCR Assay for Simultaneous Genotyping and Human T-Lymphotropic Virus Type 1, 2, and 3 Proviral Load Determination. J. Clin. Microbiol. 47: 3682-3691 [Abstract] [Full Text]  
  • Halin, M., Douceron, E., Clerc, I., Journo, C., Ko, N. L., Landry, S., Murphy, E. L., Gessain, A., Lemasson, I., Mesnard, J.-M., Barbeau, B., Mahieux, R. (2009). Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription. Blood 114: 2427-2438 [Abstract] [Full Text]  
  • Besson, G., Kazanji, M. (2009). One-Step, Multiplex, Real-Time PCR Assay with Molecular Beacon Probes for Simultaneous Detection, Differentiation, and Quantification of Human T-Cell Leukemia Virus Types 1, 2, and 3. J. Clin. Microbiol. 47: 1129-1135 [Abstract] [Full Text]  
  • Yoshida, M., Satou, Y., Yasunaga, J.-i., Fujisawa, J.-i., Matsuoka, M. (2008). Transcriptional Control of Spliced and Unspliced Human T-Cell Leukemia Virus Type 1 bZIP Factor (HBZ) Gene. J. Virol. 82: 9359-9368 [Abstract] [Full Text]  
  • Chevalier, S. A., Ko, N. L., Calattini, S., Mallet, A., Prevost, M.-C., Kehn, K., Brady, J. N., Kashanchi, F., Gessain, A., Mahieux, R. (2008). Construction and Characterization of a Human T-Cell Lymphotropic Virus Type 3 Infectious Molecular Clone. J. Virol. 82: 6747-6752 [Abstract] [Full Text]  
  • Chevalier, S. A., Walic, M., Calattini, S., Mallet, A., Prevost, M.-C., Gessain, A., Mahieux, R. (2007). Construction and Characterization of a Full-Length Infectious Simian T-Cell Lymphotropic Virus Type 3 Molecular Clone. J. Virol. 81: 6276-6285 [Abstract] [Full Text]  
  • Derse, D., Hill, S. A., Princler, G., Lloyd, P., Heidecker, G. (2007). Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid. Proc. Natl. Acad. Sci. USA 104: 2915-2920 [Abstract] [Full Text]